AU2001280176A1 - Novel ester or amide derivatives - Google Patents

Novel ester or amide derivatives

Info

Publication number
AU2001280176A1
AU2001280176A1 AU2001280176A AU8017601A AU2001280176A1 AU 2001280176 A1 AU2001280176 A1 AU 2001280176A1 AU 2001280176 A AU2001280176 A AU 2001280176A AU 8017601 A AU8017601 A AU 8017601A AU 2001280176 A1 AU2001280176 A1 AU 2001280176A1
Authority
AU
Australia
Prior art keywords
amide derivatives
novel ester
ester
novel
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280176A
Inventor
Takuya Hirata
Jun-Ichi Kazami
Masato Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU2001280176A1 publication Critical patent/AU2001280176A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001280176A 2000-08-29 2001-08-27 Novel ester or amide derivatives Abandoned AU2001280176A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000258498 2000-08-29
JP2000-258498 2000-08-29
PCT/JP2001/007307 WO2002018344A1 (en) 2000-08-29 2001-08-27 Novel ester or amide derivatives

Publications (1)

Publication Number Publication Date
AU2001280176A1 true AU2001280176A1 (en) 2002-03-13

Family

ID=18746802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280176A Abandoned AU2001280176A1 (en) 2000-08-29 2001-08-27 Novel ester or amide derivatives

Country Status (7)

Country Link
US (2) US6822098B2 (en)
EP (1) EP1314726A4 (en)
KR (1) KR20030027094A (en)
CN (1) CN1212317C (en)
AU (1) AU2001280176A1 (en)
CA (1) CA2419616A1 (en)
WO (1) WO2002018344A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4561245B2 (en) * 2004-08-31 2010-10-13 住友化学株式会社 Chromone compounds and uses thereof
KR20080007586A (en) * 2005-04-12 2008-01-22 엘란 파마 인터내셔널 리미티드 Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
EA022494B1 (en) * 2009-12-17 2016-01-29 Мерк Шарп Энд Домэ Корп. Quinoline amide compounds which are muscarinic m1 receptor positive allosteric modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151511A (en) * 1979-05-16 1980-11-26 Sankyo Co Ltd Antiallergic agent consisting mainly of kynurenic ester derivative
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
AU705883B2 (en) * 1994-10-27 1999-06-03 Fujisawa Pharmaceutical Co., Ltd. Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists
FR2733233B1 (en) * 1995-04-20 1997-05-30 Roussel Uclaf NEW QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JPH08311032A (en) * 1995-05-18 1996-11-26 Eisai Co Ltd Alpha,beta-unsaturated ketone derivative
WO1997012868A1 (en) * 1995-09-29 1997-04-10 Pfizer Pharmaceuticals Inc. Quinolone compounds for the treatment of disorders caused by helicobacter pylori
JPH09309879A (en) * 1996-05-20 1997-12-02 Eisai Co Ltd Alpha and beta-unsaturated ketone derivative
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
JP3879171B2 (en) * 1997-04-03 2007-02-07 アステラス製薬株式会社 Anti-Helicobacter pylori

Also Published As

Publication number Publication date
US7183412B2 (en) 2007-02-27
EP1314726A1 (en) 2003-05-28
US20050090497A1 (en) 2005-04-28
CN1449384A (en) 2003-10-15
EP1314726A4 (en) 2005-07-13
CA2419616A1 (en) 2003-02-13
US6822098B2 (en) 2004-11-23
WO2002018344A1 (en) 2002-03-07
CN1212317C (en) 2005-07-27
US20040019214A1 (en) 2004-01-29
KR20030027094A (en) 2003-04-03

Similar Documents

Publication Publication Date Title
AU2001271027A1 (en) Ester derivatives
AU2001241128A1 (en) Novel amide compounds
AU2001234175A1 (en) Novel cyclic amide derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001278740A1 (en) Novel phenylalanine derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001242743A1 (en) Novel phenylalanine derivative
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU5256301A (en) Froindazole derivative
AU2002214978A1 (en) Beta-Thio-amino acids
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001280176A1 (en) Novel ester or amide derivatives
AUPQ319899A0 (en) Amide compounds
AU3620099A (en) Aminomethyl-benzoic ester derivatives as tryptase inhibitors
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives